-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Eterna Therapeutics Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2023.
- Eterna Therapeutics Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$24.3M, a 25786% decline year-over-year.
- Eterna Therapeutics Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$26.2M, a 18405% decline year-over-year.
- Eterna Therapeutics Inc. annual Nonoperating Income (Expense) for 2023 was -$536K, a 106% decline from 2022.
- Eterna Therapeutics Inc. annual Nonoperating Income (Expense) for 2022 was $8.68M.
- Eterna Therapeutics Inc. annual Nonoperating Income (Expense) for 2021 was -$8.75M, a 20247% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)